Adam invests at the intersection of biology, healthcare, technology, and data. He is interested in healthcare’s digitization; genomics; coding biology; the microbiome; brain-computer interfaces; and other deep sciences. Adam invested early in Hometeam, which uses technology to improve in-home care for the elderly; Pager, which provides consumers better mobile access to healthcare; Drone Racing League, which brings drone racing to any 3-dimensional location on Earth; and Science 37, Strateos, Authorea, Zipdrug, Aptible, Alluvium and RDMD. Adam was the founding CEO and investor in Kallyope, which combines bioinformatics, sequencing, neuroimaging, and molecular biology to decode the gut-brain axis. Before joining Lux, Adam was a Postdoctoral Fellow of Neuroscience at Weill Cornell Medical College, researching regenerative stem cell medicine with brain disorders like schizophrenia and Alzheimerâs disease. Adam has dual undergraduate degrees in Business and Science and a PhD from the Australian Stem Cell Centre, where he was a Premier Scholar.